What is the price target for TYRA stock?
18 analysts have analysed TYRA and the average price target is 48.96 USD. This implies a price increase of 31.79% is expected in the next year compared to the current price of 37.15.
TYRA BIOSCIENCES INC (TYRA) Forecast, Price Target & Analyst Ratings
NASDAQ:TYRA • US90240B1061
Current stock price
37.15 USD
-1.03 (-2.7%)
At close:
37.15 USD
0 (0%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TYRA BIOSCIENCES INC (TYRA).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 6, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.60
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$48.96
Upside
+ 31.79%
From current price of $37.15 to mean target of $48.96, Based on 18 analyst forecasts
Low
$37.37
Median
$48.45
High
$61.95
Price Target Revisions
1 Month
14.97%
3 Months
52.38%
Price Target Summary
18 Wall Street analysts provided a forecast for the next 12 months for TYRA. The average price target is 48.96 USD. This implies a price increase of 31.79% is expected in the next year compared to the current price of 37.15.
The average price target has been revised upward by 52.38% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
87.78%
TYRA was analyzed by 18 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about TYRA.
In the previous month the buy percentage consensus was at a similar level.
TYRA was analyzed by 18 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-20 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-02-24 | Cantor Fitzgerald | Initiate | Overweight |
| 2026-02-17 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-02-13 | Wedbush | Maintains | Outperform -> Outperform |
| 2026-02-03 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2026-02-03 | Jefferies | Maintains | Buy -> Buy |
| 2026-01-28 | Barclays | Initiate | Overweight |
| 2026-01-23 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-12-16 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-09-03 | Raymond James | Initiate | Strong Buy |
| 2025-08-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-07-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-07 | UBS | Initiate | Buy |
| 2024-11-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-10-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-10-25 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-10-18 | B of A Securities | Upgrade | Neutral -> Buy |
| 2024-10-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-09-19 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-08-15 | Piper Sandler | Initiate | Overweight |
| 2024-08-08 | Oppenheimer | Maintains | Outperform -> Outperform |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 6, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.60
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- -28.69%
- Number of Analysts
- 14
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
1.48%
EPS (3 Months)
1.48%
Next Earnings Summary
TYRA is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.6 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 581.46% | N/A 272.12% | N/A 135.98% | N/A 40.88% | N/A 51.10% | ||||||||
| EBITDA YoY % growth | -3.11M | -9.25M -197.43% | -26.15M -182.70% | -58.63M -124.21% | -79.592M -35.75% | -103.658M -30.24% | -132.216M -27.55% | N/A -19.11% | N/A -12.15% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -3.12M | -9.3M -198.08% | -26.29M -182.69% | -58.93M -124.15% | -79.945M -35.66% | -104.177M -30.31% | -132.762M -27.44% | N/A -23.61% | N/A -18.38% | N/A -8.82% | N/A 16.37% | N/A 86.57% | N/A 1,298.77% | N/A 102.58% | N/A 70.13% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.33 4.36% | -1.61 -21.05% | -1.51 6.21% | -2.01 -33.11% | N/A -16.43% | N/A -5.10% | N/A 54.38% | N/A -10.00% | N/A 189.88% | N/A 427.13% | N/A 70.26% | N/A 51.61% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.60 -28.69% | -0.57 -20.77% | -0.59 -18.87% | -0.58 -2.00% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | -38.502M -21.43% | -38.897M -24.79% | -39.619M -21.79% | N/A |
| EBIT Q2Q % growth | -37.687M -18.33% | -38.171M -21.36% | -39.666M -20.40% | -37.667M -3.15% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
12.97%
EPS Next 5 Year
20.61%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-18.61%
EBIT Next 5 Year
N/A
TYRA BIOSCIENCES INC / TYRA Forecast FAQ
Can you provide the upcoming earnings date for TYRA BIOSCIENCES INC?
TYRA BIOSCIENCES INC (TYRA) will report earnings on 2026-05-06.
What are the consensus estimates for TYRA BIOSCIENCES INC (TYRA) next earnings?
The consensus EPS estimate for the next earnings of TYRA BIOSCIENCES INC (TYRA) is -0.6 USD and the consensus revenue estimate is 0 USD.
What is the consensus rating for TYRA stock?
The consensus rating for TYRA BIOSCIENCES INC (TYRA) is 87.7778 / 100 . This indicates that analysts generally have a positive outlook on the stock.